Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders

Abstract

PS and the number of involved sites defined three risk groups in our population. The value of these prognostic factors needs to be confirmed in larger cohorts of patients treated in prospective multicenter studies.